scholarly journals Clinical manifestation and initial treatment on infectious respiratory illnesses in HIV-infected patient: a case report

2021 ◽  
Vol 8 (7) ◽  
pp. 987
Author(s):  
Komang Septian Trisna Jaya ◽  
Ketut Suryana

Respiratory illnesses are common complication during the evolution of the disease in HIV-infected patients, mainly of infectious aetiology. Pneumocystis Pneumonia (PCP) is currently the most frequent cause of pulmonary infections in HIV patients, followed by bacterial pneumonia and TB. In this case report involves a 28 years-old male patient with HIV infection presented to the hospital with progressive dyspnoea, fever, non-productive cough and weight loss. Physical examination showed a decreased of oxygen saturation, oral thrush, and respiratory crackles in both lungs. The results of chest x-ray examination suggested a picture of pneumonia. The sputum was examined with Xpert MTB-RIF Assay and the results were negative. This patient was treated with cotrimoxazole in 2 double-strength (DS) tablets three times daily, dual therapy antibiotics combination with a beta-lactam and macrolide, oral fluconazole, also adjuvant corticosteroid of methylprednisolone. This initial treatment based on drug of choice for infectious respiratory illnesses in HIV-infected patient.

2020 ◽  
Vol 74 ◽  
pp. 348-353
Author(s):  
Hubert Ciepłucha ◽  
Brygida Knysz

Covid-19 is caused by a new virus and no effective therapy is available. The following article presents the case of a 47-year-old woman with SARS-CoV-2 infection. The infection was initially mild but because of exacerbation of the symptoms: cough, fever, headache, extreme weakness she was admitted to the hospital. The chest X-ray revealed pneumonia due to Covid-19, that is why CT was not done. Due to persistent symptoms of infection, therapy containing chloroquine and azithromycin was introduced, obtaining a very quick improvement in the condition of the infected patient. Because of ambiguous opinions of the efficacy of these two drugs in the therapy of SARS-CoV-2 infection, the authors wonder whether the improvement was either a result of the treatment with chloroquine and azithromycin or because of the natural Covid-19 course. The following part of the article briefly reviews research and world reports as well as problems connected with chloroquine and hydroxychloroquine therapy in patients with Covid-19. The current positions of the World Health Organization (WHO) and the Food and Drug Administration (FDA) in terms of the topic were also presented. It was also pointed out the way unprecedented before the therapy has been introduced based on several and variable report about the efficacy and safety of these drugs.


2018 ◽  
Vol 02 (01) ◽  
Author(s):  
Bhattacharjee B ◽  
Bhattacharya S ◽  
Ghosh M ◽  
Raj P ◽  
Sardar B ◽  
...  

Author(s):  
Oscar Westin ◽  
Abbas Ali Qayyum

Background: Recurrent episodes of isolated pericardial effusion due to tuberculosis, leading to reduced Left Ventricle Ejection Fraction (LVEF), are uncommon. Methods: This is a case report of a previously healthy 32-years old male with tuberculous induced pericardial effusion as isolated manifestation. The only known exposure of tuberculosis was a brother with whom the patient did not have physical contact during the last year. The pericardial effusion repeatedly appeared after being drained a total of three times. Due to recurrent episodes of pericardial effusion, severe thickening of the pericardium, pericardial adherences and increasing affection on the heart, pericardiectomy was ultimately performed. Results: Biochemical examination, chest X-ray, computed tomography of thorax and abdomen and cytology report did not reveal any signs of malignancy, connective tissue disease or other infections including extra-pulmonary/pulmonary tuberculosis. However, the pericardial biopsy was Polymerase Chain Reaction positive (PCR) for tuberculosis DNA and showed granulomatous inflammation with necrosis. After 6 months anti-tuberculous therapy, biochemical parameters, LVEF and the clinical condition of the patient were normalized. Conclusion: Tuberculosis can be difficult to diagnose when it only manifests as pericardial effusion especially if the time for exposure is long before the appearance of symptoms and admission.


2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Yumin Jo ◽  
Jagyung Hwang ◽  
Jieun Lee ◽  
Hansol Kang ◽  
Boohwi Hong

Abstract Background Diffuse alveolar hemorrhage (DAH) is a rare, life-threatening condition that can present as a spectrum of nonspecific symptoms, ranging from cough, dyspnea, and hemoptysis to severe hypoxemic respiratory failure. Perioperative DAH is frequently caused by negative pressure pulmonary edema resulting from acute airway obstruction, such as laryngospasm, although hemorrhage itself is rare. Case presentation This case report describes an unexpected hemoptysis following monitored anesthesia care for vertebroplasty. A 68-year-old Asian woman, with a compression fracture of the third lumbar vertebra was admitted for vertebroplasty. There were no noticeable events during the procedure. After the procedure, the patient was transferred to the postanesthesia care unit (PACU), at which sudden hemoptysis occurred. The suspected airway obstruction may have developed during transfer or immediate arrive in PACU. In postoperative chest x-ray, newly formed perihilar consolidation observed in both lung fields. The patients was transferred to a tertiary medical institution for further evaluation. She diagnosed with DAH for hemoptysis, new pulmonary infiltrates on chest x-ray and anemia. The patient received supportive care and discharged without further events. Conclusions Short duration of airway obstruction may cause DAH, it should be considered in the differential diagnosis of postoperative hemoptysis of unknown etiology.


2009 ◽  
Vol 3 (1) ◽  
pp. 138
Author(s):  
L.J. Grando ◽  
S.M. Fabro ◽  
M.I. Meurer ◽  
L.I. Ching ◽  
M.A. Domingues ◽  
...  

2001 ◽  
Vol 87 (2) ◽  
pp. 111-112
Author(s):  
Jon Matthews ◽  
Giles W Beck ◽  
Douglas M G Bowley ◽  
Andrew N Kingsnorth

AbstractThe case of a 31 year old male presenting as an emergency with a recurrent colonic volvulus is described. A chest X-ray on admission to hospital showed the presence of hepato-diaphragmatic interposition of the colon, Chilaiditi’s Sign, which is known to be a risk factor for colonic volvulus. This is only the fourth reported case of colonic volvulus in association with Chilaiditi’s Syndrome and the first with recurrent colonic volvulus. The optimal treatment for recurrent volvulus in patients with risk factors such as Chilaiditi’s Syndrome or megacolon is also discussed.


2014 ◽  
Vol 56 (5) ◽  
pp. 439-442 ◽  
Author(s):  
Cláudia Maria Valete-Rosalino ◽  
Maria Helena Araujo-Melo ◽  
Débora Cristina de Oliveira Bezerra ◽  
Renata Oliveira de Barcelos ◽  
Vanessa de Melo-Ferreira ◽  
...  

Introduction: Pentavalent antimonials are the first drug of choice in the treatment of tegumentary leishmaniasis. Data on ototoxicity related with such drugs is scarcely available in literature, leading us to develop a study on cochleovestibular functions. Case Report: A case of a tegumentary leishmaniasis patient, a 78-year-old man who presented a substantial increase in auditory threshold with tinnitus and severe rotatory dizziness during the treatment with meglumine antimoniate, is reported. These symptoms worsened in two weeks after treatment was interrupted. Conclusion: Dizziness and tinnitus had already been related to meglumine antimoniate. However, this is the first well documented case of cochlear-vestibular toxicity related to meglumine antimoniate.


Sign in / Sign up

Export Citation Format

Share Document